Walker Caroline H, Arora Sumant S, Colantonio Lisandro D, Kakati Donny D, Fitzmorris Paul S, Chu Daniel I, Malik Talha A
Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Department of Internal Medicine, University of Alabama at Birmingham, Montgomery, AL, USA.
Gastroenterol Rep (Oxf). 2017 Nov;5(4):288-292. doi: 10.1093/gastro/gow036. Epub 2016 Dec 10.
There is equivocal evidence regarding differences in the clinical course and outcomes of Crohn's disease (CD) among African Americans compared with Caucasian Americans. We sought to analyze whether African Americans with CD are more likely to be hospitalized for CD-related complications when compared with Caucasian Americans with CD.
We conducted a retrospective cohort study including 909 African Americans and Caucasian Americans with CD who were seen at our tertiary care Inflammatory Bowel Disease (IBD) referral center between 2000 and 2013. We calculated the rate of hospitalization for CD-related complications among African Americans and Caucasian Americans separately. Zero-inflated Poisson regression models with robust variance estimates were used to estimate crude and multivariable adjusted rate ratios (RR) for CD-related hospitalizations. Multivariable adjusted models included adjustment for age, sex, duration of CD, smoking and CD therapy.
The cumulative rate of CD-related hospital admissions was higher among African American patients compared with Caucasian American patients (395.6/1000 person-years in African Americans vs. 230.4/1000 person-years in Caucasian Americans). Unadjusted and multivariable adjusted rate ratios for CD-related hospitalization comparing African Americans and Caucasian Americans were 1.59 (95% confidence interval [95%CI]: 1.10-2.29; P=0.01) and 1.44 (95%CI: 1.02-2.03; P=0.04), respectively.
African Americans with CD followed at a tertiary IBD-referral center had a higher rate for CD-related hospitalizations compared with Caucasian Americans. Future studies should examine whether socioeconomic status and biologic markers of disease status could explain the higher risk observed among African Americans.
关于非裔美国人和美国白人克罗恩病(CD)临床病程及预后差异的证据并不明确。我们试图分析与患有CD的美国白人相比,患有CD的非裔美国人是否更有可能因CD相关并发症而住院。
我们进行了一项回顾性队列研究,纳入了2000年至2013年间在我们的三级医疗炎症性肠病(IBD)转诊中心就诊的909名患有CD的非裔美国人和美国白人。我们分别计算了非裔美国人和美国白人中CD相关并发症的住院率。使用具有稳健方差估计的零膨胀泊松回归模型来估计CD相关住院的粗率和多变量调整率比(RR)。多变量调整模型包括对年龄、性别、CD病程、吸烟和CD治疗的调整。
与美国白人患者相比,非裔美国患者中CD相关住院的累积率更高(非裔美国人中为395.6/1000人年,美国白人中为230.4/1000人年)。比较非裔美国人和美国白人CD相关住院的未调整和多变量调整率比分别为1.59(95%置信区间[95%CI]:1.10 - 2.29;P = 0.01)和1.44(95%CI:1.02 - 2.03;P = 0.04)。
在三级IBD转诊中心接受随访的患有CD的非裔美国人与美国白人相比,CD相关住院率更高。未来的研究应探讨社会经济地位和疾病状态的生物学标志物是否可以解释在非裔美国人中观察到的较高风险。